Charles Schwab Investment Management Inc. Grows Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Charles Schwab Investment Management Inc. raised its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,133,873 shares of the company's stock after purchasing an additional 69,649 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.94% of Privia Health Group worth $22,167,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Nordea Investment Management AB grew its stake in shares of Privia Health Group by 33.1% during the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock valued at $6,953,000 after purchasing an additional 86,910 shares during the period. Victory Capital Management Inc. grew its stake in shares of Privia Health Group by 402.9% during the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company's stock valued at $3,260,000 after purchasing an additional 143,446 shares during the period. Rhumbline Advisers grew its stake in shares of Privia Health Group by 1.3% during the 4th quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock valued at $5,615,000 after purchasing an additional 3,658 shares during the period. Franklin Resources Inc. grew its stake in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after purchasing an additional 28,480 shares during the period. Finally, Barclays PLC grew its stake in shares of Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after purchasing an additional 158,188 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on PRVA shares. Stephens reiterated an "overweight" rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Macquarie started coverage on Privia Health Group in a research note on Monday, December 16th. They set an "outperform" rating and a $25.00 price objective for the company. Canaccord Genuity Group boosted their price objective on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, February 28th. Needham & Company LLC reiterated a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research note on Friday. Finally, JPMorgan Chase & Co. boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Friday, November 29th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $26.67.

Privia Health Group Stock Performance

Shares of PRVA traded up $0.05 during mid-day trading on Friday, hitting $23.34. 1,471,814 shares of the stock were exchanged, compared to its average volume of 754,045. The company has a market cap of $2.81 billion, a PE ratio of 233.42, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The firm has a 50-day moving average of $23.65 and a two-hundred day moving average of $21.02.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.